MY131426A - Hematopoietic arabinogalactan composition - Google Patents
Hematopoietic arabinogalactan compositionInfo
- Publication number
- MY131426A MY131426A MYPI20003006A MYPI20003006A MY131426A MY 131426 A MY131426 A MY 131426A MY PI20003006 A MYPI20003006 A MY PI20003006A MY PI20003006 A MYPI20003006 A MY PI20003006A MY 131426 A MY131426 A MY 131426A
- Authority
- MY
- Malaysia
- Prior art keywords
- stimulating
- exposure
- arabinogalactan
- compositions
- csf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURIFIED ARABINOGALACTAN COMPOSITIONS ISOLATED FROM THE ROOTS OF ASTAGALUS MEMBRANACEUS, AND ARABINOGALACTAN PROTEIN COMPOSITIONS HAVING A WEIGHT AVERAGE MOLECULAR WEIGHT OF AT LEAST 100 KILODALTONS ISOLATED FROM THESE PURIFIED ARABINOGALACTAN COMPOSITIONS, ARE CAPABLE OF RECONSTITUTION INTO AQUEOUS INTRAVENOUSLY INJECTABLE FORMULATIONS; AND ARE USEFUL FOR STIMULATING HEMA TOPOIESIS, INDUCING THE PROLIFERATION OR MATURATION OF MEGAKARYOCYTES, STIMULATING THE PRODUCTION OF IL-Iβ, IL-6, TNF-α, IFN-У, GM-CSF, OR G-CSF, STIMULATING THE PRODUCTION OR ACTION OF NEUTROPHILS, TREATING NEUTROPENIA, ANEMIA, OR THROMBOCYTOPENIA, ACCELERATING RECOVERY FROM EXPOSURE (E.G. ACCIDENTAL OR NON-THERAPEUTIC EXPOSURE, ASWELL AS THERPEUTIC EXPOSURE) TO CYTOTOXIS AGENTS OR RADIATION, TREATING CACHEXIA, EMESIS, OR DRUG WITHDRAWAL SYSMTOMS, OR MODIFYING BIOLOGICAL RESPONSES OR PROTECTING HEPATIC CELLS IN HEPATITIS B, IN AMAMMAL WHEN INTRAVENOUSLY ADMINISTERED TO THE MAMMAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14203199P | 1999-06-30 | 1999-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY131426A true MY131426A (en) | 2007-08-30 |
Family
ID=22498290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20003006A MY131426A (en) | 1999-06-30 | 2000-06-30 | Hematopoietic arabinogalactan composition |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1200482A1 (en) |
| CN (1) | CN1179979C (en) |
| AU (1) | AU6203600A (en) |
| HK (1) | HK1046290B (en) |
| MY (1) | MY131426A (en) |
| TW (1) | TWI240629B (en) |
| WO (1) | WO2001000682A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002002607A2 (en) * | 2000-06-29 | 2002-01-10 | Pharmagenesis, Inc. | Acid-modified arabinogalactan protein composition |
| US7601368B2 (en) | 2004-09-01 | 2009-10-13 | Lupin Limited | Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders |
| CN1854158B (en) * | 2005-04-25 | 2011-09-07 | 蒋来高 | Extraction of astragalus mongholicus polysaccharose by super-critical fluid technology |
| MY159317A (en) | 2008-12-15 | 2016-12-30 | Ecopharm Corp | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
| JP2017525702A (en) * | 2014-08-18 | 2017-09-07 | ファーマジェネシス， インコーポレイテッド | Polygalacturonan rhamnogalacturonan (PGRG1) composition |
| CN104147254A (en) * | 2014-08-21 | 2014-11-19 | 陈勇 | Traditional Chinese medicine preparation for treating leucocytopenia after chemotherapy |
| CN109432242A (en) * | 2018-11-07 | 2019-03-08 | 郑毅男 | A kind of larch arabinogalactan preparation method and its application in terms of medical treatment |
| CN110551230B (en) * | 2019-09-21 | 2022-02-15 | 天津赛诺制药有限公司 | Preparation method of astragalus polysaccharide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589591A (en) * | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
| US4944946A (en) * | 1987-01-27 | 1990-07-31 | Yaguang Liu | Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
| CN1027168C (en) * | 1989-05-13 | 1994-12-28 | 储大同 | Bioregulator made from Inter leukin-2 |
| IT1238685B (en) * | 1990-02-09 | 1993-09-01 | Indena Spa | IMMUNOMODULATING ACTION POLYSACCHARIDES FROM ASTRAGALUS MEMBRANACEOUS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
| US5116969B1 (en) * | 1990-04-26 | 1997-04-01 | Larex International Inc | Ultrarefined arabinogalactan product |
| ES2049561B1 (en) * | 1991-04-27 | 1994-12-16 | Andromaco Lab | PROCEDURE FOR OBTAINING POLYMERS WITH ACTIVITY ON THE HEMATOPOYETIC SYSTEM. |
| US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
-
2000
- 2000-06-30 WO PCT/US2000/018180 patent/WO2001000682A1/en not_active Application Discontinuation
- 2000-06-30 AU AU62036/00A patent/AU6203600A/en not_active Abandoned
- 2000-06-30 MY MYPI20003006A patent/MY131426A/en unknown
- 2000-06-30 EP EP00948559A patent/EP1200482A1/en not_active Withdrawn
- 2000-06-30 TW TW089112971A patent/TWI240629B/en not_active IP Right Cessation
- 2000-06-30 CN CNB008115478A patent/CN1179979C/en not_active Expired - Lifetime
-
2002
- 2002-10-29 HK HK02107822.7A patent/HK1046290B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1046290A1 (en) | 2003-01-03 |
| HK1046290B (en) | 2005-08-12 |
| WO2001000682A1 (en) | 2001-01-04 |
| TWI240629B (en) | 2005-10-01 |
| EP1200482A1 (en) | 2002-05-02 |
| AU6203600A (en) | 2001-01-31 |
| CN1368979A (en) | 2002-09-11 |
| CN1179979C (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| WO2000057851A3 (en) | High potency dihydroergotamine compositions | |
| JP2003519478A5 (en) | ||
| NO20034492L (en) | HSA-free formulations of Interferon <beta> | |
| TW221378B (en) | ||
| CA2387058A1 (en) | Injection vehicle for polymer-based formulations | |
| EP1164133A3 (en) | Enantiomerically pure Beta-D-(-)-dioxolane-nucleosides | |
| ES2026469T3 (en) | PREPARATION PROCEDURE OF AN EROSIONABLE AND MOLDABLE COMPOSITION BY INJECTION. | |
| PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
| AU8018187A (en) | Pharmaceutical compositions of recombinant interleukin-2 and formulation process | |
| NZ516664A (en) | Formulations and compositions for interleukin-11 | |
| PL316942A1 (en) | Novel pharmaceutic compositions based on taxoides | |
| AP2001002302A0 (en) | 13-Methyl erythromycin derivatives. | |
| MY131426A (en) | Hematopoietic arabinogalactan composition | |
| MY137547A (en) | Acid-modified arabinogalactan protein composition | |
| IL155788A (en) | Composition comprising biologically active ifn--beta and highly purified mannitol, a method of producing a formulation of biologically active ifn-beta having improved stability and a method for increasing the stability of biologically active ifn-beta in a composition | |
| IL100162A0 (en) | Oral pharmaceutical composition containing cyclosporin and its preparation | |
| KR900700124A (en) | Therapeutic Compositions of IL-2 and DTIC for Treatment of Melanoma | |
| ES2105923B1 (en) | COMPOSITIONS FOR THE TREATMENT OF AN INFECTION AND DISEASE CAUSED BY THE HEPATITIS B (HBV) VIRUS. | |
| DK0524696T3 (en) | Oral preparations containing dapiprazole | |
| CA2255856A1 (en) | Therapeutic uses for an aminosterol compound | |
| IT1204778B (en) | INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS FOR GENERAL ANESTHETIC ACTIVITIES | |
| CA2458690A1 (en) | Pharmaceutical compositions comprising an ascomycin derivative | |
| FR2701952B1 (en) | New cyclopeptide derivatives of angiopeptin, their preparation process and the pharmaceutical compositions containing them. |